Yoshihiko Fujita, Hiromichi Matsuoka, Yasutaka Chiba, Junji Tsurutani, Takeshi Yoshida, Kiyohiro Sakai, Miki Nakura, Ryo Sakamoto, Chihiro Makimura, Yoichi Ohtake, et al. Dual single-nucleotide polymorphism biomarker combination for opioid selection to treat cancer pain. Molecular and clinical oncology. 2025. 22. 2. 14-14
Masayuki Takeda, Masahide Ota, Eiji Iwama, Shunichi Sugawara, Takehito Shukuya, Shigeki Umemura, Hiroshi Tanaka, Masahide Oki, Takayuki Takahama, Takeshi Masuda, et al. A Phase II, Open Label, Single-Arm Study on the Efficacy of Cabozantinib in Patients With Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring MET Exon 14 Alterations who Developed Acquired Resistance to Tepotinib or Capmatinib (CAPTURE Trial). Clinical lung cancer. 2024
Tomohiro Nakayama, Takayuki Takahama, Yasutaka Chiba, Naoki Shiraishi, Hisato Kawakami, Kimio Yonesaka, Kazuhiko Nakagawa, Hidetoshi Hayashi. Evaluation of immune checkpoint inhibitor efficacy for solid tumors withCD274(PD-L1 gene) amplification identified by comprehensive genomic profiling: retrospective study based on a nationwide database. Journal for ImmunoTherapy of Cancer. 2024. 12. 12
Satoshi Ikeda, Kazuo Hasegawa, Kenta Kachi, Akihiro Yanagisawa, Sachiko Kawakami, Shinsuke Hamasaki, Sachiko Watanabe, Aki Yoshikawa, Takayuki Takahama, Kazuhiko Nakagawa. Patient-Initiated Nationwide Survey on Testing for Actionable Oncogenic Drivers in Non-Small Cell Lung Cancer in Japan. Cancer medicine. 2024. 13. 21. e70375
Luis G. Paz-Ares, Oscar Juan-Vidal, Giannis S. Mountzios, Enriqueta Felip, Niels Reinmuth, Filippo de Marinis, Nicolas Girard, Vipul M. Patel, Takayuki Takahama, Scott P. Owen, et al. Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study. Journal of Clinical Oncology. 2024. 42. 24. JCO2400733-2872